It was reported that YTHDF2 was overexpressed in both bladder cancer and prostate cancer  (PCa) [65–67] and was remarkably downregulated in clear cell renal cell carcinoma (ccRCC) [68]. Here, YTHDF2 is linked to urinary bladder carcinoma.